PGBHX | RGACX | PGBHX / RGACX | |
Total Expense Ratio | 0.57 | 0.94 | 61% |
Annual Report Gross Expense Ratio | 0.60 | 0.94 | 64% |
Fund Existence | 9 years | 23 years | - |
Gain YTD | 11.331 | 15.516 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.5B | 332B | 3% |
Annual Yield % from dividends | 0.10 | 0.07 | 140% |
Returns for 1 year | 14.46 | 17.83 | 81% |
Returns for 3 years | 71.10 | 58.53 | 121% |
Returns for 5 years | 53.42 | 40.02 | 133% |
Returns for 10 years | N/A | 95.93 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MUU | 26.19 | 2.71 | +11.54% |
Direxion Daily MU Bull 2X Shares | |||
WLTG | 33.62 | -0.02 | -0.07% |
WealthTrust DBS Long Term Growth ETF | |||
IQSU | 51.58 | -0.12 | -0.24% |
NYLI Candriam U.S. Large Cap Equity ETF | |||
ILCB | 89.77 | -0.26 | -0.29% |
iShares Morningstar U.S. Equity ETF | |||
BIS | 13.46 | -0.48 | -3.41% |
ProShares UltraShort Nasdaq Biotech |